Author

F. Torrigiani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Dalla Pieta· 1 shared A. Penna· 1 shared A. Rigillo· 1 shared A. Rosato· 1 shared B. Bussolati· 1 shared C. Gola· 1 shared C. Salata· 1 shared D. Cacchiarelli· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Dalla Pieta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NON-TOXIC ACID-FREE GLYOXAL FIXATIVE FOR VETERINARY HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND MOLECULAR ANALYSIS

V. Zappulli, F. Torrigiani, V. Moccia, P. Detillo, C. Gola, L. Minoli, E. M. Morello, E. I. Ferraris, A. Rigillo, F. Caicci, G. Dalla Rovere, D. De Biase, L. Riccio, M. Rondena, S. Iussich, B. Bussolati

This study compares a non-toxic Glyoxal fixative with formaldehyde in veterinary pathology, finding better molecular preservation and comparable histological results.

bioRxiv · May 5, 2023Pathology

Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern

I. Frasson, L. Diamante, M. Zangrossi, E. Carbognin, A. Dalla Pieta, A. Penna, A. Rosato, R. Verin, F. Torrigiani, C. Salata, L. Vaccaro, D. Cacchiarelli, S. N. Richter, M. Montagner, G. Martello

This study identifies shared host dependency factors across multiple SARS-CoV-2 variants and shows antioxidant drugs are effective against all tested variants.

bioRxiv · Jan 9, 2023Microbiology